Drug to treat agitation in Alzheimer’s patients approved in Canada – National
Health Canada has green lit a drug previously approved for schizophrenia and depression to treat symptoms of agitation in Alzheimer’s patients. Rexulti (brexpiprazole) oral tablets manufactured by Otsuka Pharmaceutical Canada …